Avanzarx is a bio-pharmaceutical company creating breakthrough therapeutics by combining computational (AI/ML) approaches with deep fundamental insights into systems biology and structure-based drug discovery to tackle the most difficult challenges in small molecule drug discovery. We are designed as a hyper capital-efficient, therapeutic asset engine to provide turn-key pipeline assets to established pharma companies.